SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Celestial Biolabs - Quaterly Results

29 Mar 2024 Evaluate
The Revenue for the quarter ended  December 2023 of Rs. 0.37 millions grew by 8.82 % from Rs. 0.34 millions.The Net Loss for the quarter ended December 2023 is Rs. -0.35 millions as compared to Net Loss of Rs. -1.54 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 improved to -0.29% as compared to -1.46% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.37 0.34 8.82 0.96 1.31 -26.72 1.69 1.48 14.19
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.29 -1.46 -80.14 -1.48 -3.14 -52.87 -5.41 -3.79 42.74
Interest 0.01 0.01 0.00 0.01 0.02 -50.00 0.02 0.00 0.00
PBDT -0.30 -1.47 -79.59 -1.49 -3.16 -52.85 -5.43 -3.79 43.27
Depreciation 0.05 0.07 -28.57 0.15 0.21 -28.57 0.28 0.30 -6.67
PBT -0.35 -1.54 -77.27 -1.64 -3.37 -51.34 -5.71 -4.09 39.61
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.35 -1.54 -77.27 -1.64 -3.37 -51.34 -5.71 -4.09 39.61
Equity 225.86 225.86 0.00 225.86 225.86 0.00 225.86 225.86 0.00
PBIDTM(%) -78.38 -429.41 -81.75 -154.17 -239.69 -35.68 -320.12 -256.08 25.01

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×